Chris T. Bitterman's most recent trade in Cumberland Pharmaceuticals Inc. was a trade of 2,750 Options (right to buy) done . Disclosure was reported to the exchange on March 17, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cumberland Pharmaceuticals... | Chris T. Bitterman | Vice Pres Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Mar 2025 | 2,750 | 16,000 | - | - | Options (right to buy) | |
Cumberland Pharmaceuticals... | Chris T. Bitterman | Vice Pres Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Mar 2024 | 2,750 | 13,250 | - | - | Options (right to buy) | |
Cumberland Pharmaceuticals... | Chris T. Bitterman | Vice Pres Sales & Marketing | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.81 per share. | 23 Mar 2024 | 593 | 4,683 (0%) | 0% | 1.8 | 1,073 | Common Stock |
Cumberland Pharmaceuticals... | Chris T. Bitterman | Vice Pres Sales & Marketing | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Mar 2023 | 5,500 | 12,500 | - | - | Options (right to buy) |